Biosenta Announces Closing of Previously Announced Transaction
Biosenta Announces Closing of Previously Announced Transaction
Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has entered into debt settlement agreements with certain creditors, pursuant to which the Company agreed to settle an aggregate amount of $784,919 in outstanding debt (the "Transaction") in exchange for the issuance of 1,962,297 units at a price of $0.40 per unit (each, a "Unit"), in accordance with the policies of the Canadian Securities Exchange.
安大略省多倫多--（Newsfile Corp.，2024 年 2 月 21 日）——Biosenta Inc.（CSE：ZRO）（”公司“或”Biosenta“），很高興地宣佈，它已與某些債權人簽訂了債務清算協議，根據該協議，公司同意償還總額爲784,919美元的未償債務（”交易“) 以每單位0.40美元的價格發行1,962,297個單位（每個，a）”單元“），根據加拿大證券交易所的政策。
Each Unit consists of one common share of the Company (each a, "Common Share") and one half of one common share purchase warrants (each whole warrant, a "Warrant"). Each Warrant entitles the holder thereof to acquire, subject to adjustment in certain events, one Common Share at an exercise price of $0.80 for a period of 18 months from the Transaction closing date.
每個單位由公司的一股普通股組成（每股 a，”普通股“) 以及一份普通股購買權證的一半（每份完整認股權證，a）搜查令“）。每份認股權證的持有人有權在自交易截止日起的18個月內以0.80美元的行使價收購一股普通股，但須在某些情況下進行調整。
The securities that were issued are subject to a four-month plus one day "hold period" expiring June 22, 2024, as prescribed by applicable Canadian securities laws.
根據適用的加拿大證券法的規定，已發行的證券有四個月加一天的 “持有期”，將於2024年6月22日到期。
As a result of the issuance, there are 29,618,888 Common Shares of Biosenta issued and outstanding on a non-diluted basis.
此次發行後，Biosenta共發行和流通了29,618,888股普通股，未攤薄。
The Transaction does not otherwise affect Biosenta's day-to-day business and affairs.
該交易不會以其他方式影響Biosenta的日常業務和事務。
Further details of the Transaction can be found in Biosenta's press release dated January 31, 2024, and the material change report in connection therewith filed on January 31, 2024, each of which are available under Biosenta's profile on SEDAR+ at .
該交易的更多細節可以在Biosenta於2024年1月31日發佈的新聞稿以及2024年1月31日提交的與此相關的重大變更報告中找到，每份報告均可在Biosenta在SEDAR+上的個人資料下查閱，網址爲。
About Biosenta Inc.
關於 Biosenta Inc.
Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.
Biosenta是一家總部位於加拿大的公司，爲家庭和工業應用開發和製造一系列安全和環保的化合物。
For further details on the Company please see the Company's publicly available documents filed on the System for Electronic Document Analysis and Retrieval+ (SEDAR+).
有關公司的更多詳細信息，請參閱公司在電子文件分析和檢索系統（SEDAR+）上提交的公開文件。
For further information please contact:
欲了解更多信息，請聯繫：
Am Gill, President and CEO of Biosenta Inc. | Phone: 416-410-2019
Biosenta Inc. 總裁兼首席執行官阿姆·吉爾 | 電話：416-410-2019
譯文內容由第三人軟體翻譯。